Literature DB >> 29158437

Cardiac Magnetic Resonance Imaging in Myocarditis Reveals Persistent Disease Activity Despite Normalization of Cardiac Enzymes and Inflammatory Parameters at 3-Month Follow-Up.

Jan Berg1, Jan Kottwitz1, Nora Baltensperger1, Christine K Kissel1, Marina Lovrinovic1, Tarun Mehra1, Frank Scherff1, Christian Schmied1, Christian Templin1, Thomas F Lüscher1, Bettina Heidecker2, Robert Manka1.   

Abstract

BACKGROUND: There is a major unmet need to identify high-risk patients in myocarditis. Although decreasing cardiac and inflammatory markers are commonly interpreted as resolving myocarditis, this assumption has not been confirmed as of today. We sought to evaluate whether routine laboratory parameters at diagnosis predict dynamic of late gadolinium enhancement (LGE) as persistent LGE has been shown to be a risk marker in myocarditis. METHODS AND
RESULTS: Myocarditis was diagnosed based on clinical presentation, high-sensitivity troponin T, and cardiac magnetic resonance imaging, after exclusion of obstructive coronary artery disease by angiography. Cardiac magnetic resonance imaging was repeated at 3 months. LGE extent was analyzed with the software GT Volume. Change in LGE >20% was considered significant. Investigated cardiac and inflammatory markers included high-sensitivity troponin T, creatine kinase, myoglobin, N-terminal B-type natriuretic peptide, C-reactive protein, and leukocyte count. Twenty-four patients were enrolled. Absolute levels of cardiac enzymes and inflammatory markers at baseline did not predict change in LGE at 3 months. Cardiac and inflammatory markers had normalized in 21 patients (88%). LGE significantly improved in 16 patients (67%); however, it persisted to a lesser degree in 17 of them (71%) and increased in a small percentage (21%) despite normalization of cardiac enzymes.
CONCLUSIONS: This is the first study reporting that cardiac enzymes and inflammatory parameters do not sufficiently reflect LGE in myocarditis. Although a majority of patients with normalizing laboratory markers experienced improved LGE, in a small percentage LGE worsened. These data suggest that cardiac magnetic resonance imaging might add value to currently existing diagnostic tools for risk assessment in myocarditis.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  biomarkers; creatine kinase; magnetic resonance imaging; myocarditis; myoglobin; natriuretic peptide, brain; troponin

Mesh:

Substances:

Year:  2017        PMID: 29158437     DOI: 10.1161/CIRCHEARTFAILURE.117.004262

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  16 in total

1.  Radiomics for Distinguishing Myocardial Infarction from Myocarditis at Late Gadolinium Enhancement at MRI: Comparison with Subjective Visual Analysis.

Authors:  Tommaso Di Noto; Jochen von Spiczak; Manoj Mannil; Elena Gantert; Paolo Soda; Robert Manka; Hatem Alkadhi
Journal:  Radiol Cardiothorac Imaging       Date:  2019-12-19

Review 2.  [Dermatomyositis and juvenile dermatomyositis].

Authors:  Frank Dressler; Britta Maurer
Journal:  Z Rheumatol       Date:  2022-04-29       Impact factor: 1.372

Review 3.  Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy.

Authors:  Sophie Van Linthout; Carsten Tschöpe
Journal:  Curr Opin Cardiol       Date:  2018-05       Impact factor: 2.161

4.  Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up.

Authors:  Jan Berg; Marina Lovrinovic; Nora Baltensperger; Christine K Kissel; Jan Kottwitz; Robert Manka; Dimitri Patriki; Frank Scherff; Christian Schmied; Ulf Landmesser; Thomas F Lüscher; Bettina Heidecker
Journal:  Open Heart       Date:  2019-04-23

5.  Myoglobin for Detection of High-Risk Patients with Acute Myocarditis.

Authors:  Jan Kottwitz; Katelyn A Bruno; Jan Berg; Gary R Salomon; DeLisa Fairweather; Mawahib Elhassan; Nora Baltensperger; Christine K Kissel; Marina Lovrinovic; Andrea Baltensweiler; Christian Schmied; Christian Templin; Joao A C Lima; Ulf Landmesser; Thomas F Lüscher; Robert Manka; Bettina Heidecker
Journal:  J Cardiovasc Transl Res       Date:  2020-01-31       Impact factor: 3.216

Review 6.  Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis.

Authors:  Saagar K Sanghvi; Logan S Schwarzman; Noreen T Nazir
Journal:  Diagnostics (Basel)       Date:  2021-01-15

7.  COVID-19-Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group.

Authors:  James McKinney; Kim A Connelly; Paul Dorian; Anne Fournier; Jack M Goodman; Nicholas Grubic; Saul Isserow; Nathaniel Moulson; François Philippon; Andrew Pipe; Paul Poirier; Taryn Taylor; Jane Thornton; Mike Wilkinson; Amer M Johri
Journal:  Can J Cardiol       Date:  2020-11-26       Impact factor: 5.223

Review 8.  Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.

Authors:  Carsten Tschöpe; Enrico Ammirati; Biykem Bozkurt; Alida L P Caforio; Leslie T Cooper; Stephan B Felix; Joshua M Hare; Bettina Heidecker; Stephane Heymans; Norbert Hübner; Sebastian Kelle; Karin Klingel; Henrike Maatz; Abdul S Parwani; Frank Spillmann; Randall C Starling; Hiroyuki Tsutsui; Petar Seferovic; Sophie Van Linthout
Journal:  Nat Rev Cardiol       Date:  2020-10-12       Impact factor: 49.421

9.  Comparison of 3D and 2D late gadolinium enhancement magnetic resonance imaging in patients with acute and chronic myocarditis.

Authors:  M Polacin; I Kapos; M Gastl; C Blüthgen; M Karolyi; J von Spiczak; M Eberhard; B Baessler; H Alkadhi; S Kozerke; R Manka
Journal:  Int J Cardiovasc Imaging       Date:  2020-08-13       Impact factor: 2.357

10.  Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance.

Authors:  Hui Wang; Ruili Li; Zhen Zhou; Hong Jiang; Zixu Yan; Xinyan Tao; Hongjun Li; Lei Xu
Journal:  J Cardiovasc Magn Reson       Date:  2021-02-25       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.